Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

August 23, 2024

Study Completion Date

August 23, 2024

Conditions
Neurofibromatosis 1
Interventions
DIAGNOSTIC_TEST

Blood draw

• An additional 10 mL of blood will then be drawn for mitochondrial testing purposes.

OTHER

FACIT-F and Pain Scales

• Questionnaires regarding pain and fatigue will be provided for the subject to review and answer.

Trial Locations (1)

72205

University of Arkansas For Medical Sciences, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER